Holen Sie sich die Stockscreener-App
0.3473
6.46%
-0.024
Handel nachbörslich:
.34
-0.0073
-2.10%
Finanzdaten der Cyclacel Pharmaceuticals Inc-Aktie (CYCC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
6.45%
0.029
|
0.031 | 0.016 | 0.373 | - |
Operating Expenses
|
18.68%
4.384
|
5.391 | 6.861 | 6.302 | 7.319 |
| Benefits Costs and Expenses |
24.37%
4.329
|
5.724 | 6.716 | 6.407 | 7.124 |
| Costs And Expenses |
24.37%
4.329
|
5.724 | 6.716 | 6.407 | 7.124 |
| Operating Income/Loss |
18.75%
-4.355
|
-5.36 | -6.845 | -5.929 | -7.319 |
| Nonoperating Income/Loss |
116.52%
0.055
|
-0.333 | 0.145 | -0.105 | 0.195 |
| Income/Loss From Continuing Operations Before Tax |
24.47%
-4.30
|
-5.693 | -6.70 | -6.034 | -7.124 |
| Income Tax Expense/Benefit |
220.85%
-1.354
|
-0.422 | -0.668 | -0.586 | -1.32 |
| Income/Loss From Continuing Operations After Tax |
44.11%
-2.946
|
-5.271 | -6.032 | -5.448 | -5.804 |
|
Net Income/Loss
|
44.58%
-2.946
|
-5.316 | -6.032 | -5.448 | -5.804 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Diluted Earnings Per Share |
-2.27
|
- | - | -0.44 | -0.47 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):